Pastille

Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia

Retrieved on: 
Monday, March 4, 2024
ACB, AB, TSX, Growth, Oil, Pastille, Health, Patient

EDMONTON, AB, March 4, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced today the availability of medical cannabis pastilles for doctors to prescribe to patients in Australia.

Key Points: 
  • EDMONTON, AB, March 4, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced today the availability of medical cannabis pastilles for doctors to prescribe to patients in Australia.
  • The novel product is produced by Aurora and distributed by MedReleaf Australia, a leading distributor of medical cannabis products with the number two position in the Australian market.
  • "The introduction of innovative and differentiated products, such as pastilles, and planned upcoming innovation, will provide Australian doctors expanded options for patient care and enhance patient access to the premium medical cannabis they seek," continued Jerome.
  • "Our pre-dosed pastilles broaden our range of high quality, medical cannabis offerings and cater to all patient groups who may find the taste of oil or flower undesirable, providing a discrete, portable and cost effective alternative for those seeking medical cannabis as part of their regime," said Viccars.

Throat Pastilles and Cough Drops Market- Roadmap for Recovery from COVID-19 | Emergence of Innovative Products to Boost Market Growth | Technavio

Retrieved on: 
Monday, September 28, 2020
Retail, Other Retail, Health, Medicine, Articles, Throat lozenge, Pastille, Segment, Coronavirus disease, Image segmentation

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.
  • Download a Free Sample Report on COVID-19 Impacts
    Based on segmentation by type, which is the leading segment in the market?
  • Throat Pastilles and Cough Drops Market 2020-2024: Segmentation
    Throat Pastilles and Cough Drops Market is segmented as below:

Assessment of COVID-19's Effect on Throat Pastilles and Cough Drops Market 2020-2024 | Emergence of Innovative Products to Augment Growth | Technavio

Retrieved on: 
Thursday, June 18, 2020
Health, Pharmaceutical, Medicine, Clinical medicine, Health, Throat lozenge, Pastille, Cough, Drops, Market research

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • View the full release here: https://www.businesswire.com/news/home/20200618005596/en/
    Technavio has announced its latest market research report titled Global Throat Pastilles and Cough Drops Market 2020-2024 (Graphic: Business Wire)
    Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied.
  • The emergence of innovative products has been instrumental in driving the growth of the market.
  • https://www.technavio.com/report/report/throat-pastilles-and-cough-drops...
    Throat Pastilles and Cough Drops Market 2020-2024: Segmentation
    Throat Pastilles and Cough Drops Market is segmented as below:

Cool Day’s Healthy Mint Lozenges are Coming to America

Retrieved on: 
Thursday, April 2, 2020
Monoterpenes, Chemistry, Medicine, Physical sciences, Confectionery, Pastille, Eucalyptol, Chewing gum, Menthol, Lozenge

As we grewin popularity, we added new variations of the original ValdaClassic, which will be known as Cool Dayin America.

Key Points: 
  • As we grewin popularity, we added new variations of the original ValdaClassic, which will be known as Cool Dayin America.
  • Twelve years later, the Valda lozenge arrived in Brazil, where it became an instant hit with the Brazilian consumers.
  • Todays pastilles ingredients include Acacia gum and natural ingredients such as menthol, eucalyptol, prpolis, and ginger, which makes Cool Dayunique and special.
  • Cool Day, or Valda, lozenges are known as one of the worlds first pharmaceutical products.

Global Throat Pastilles and Cough Drops Market 2020-2024 | Evolving Opportunities With Kestrel Medical Ltd. and Pfizer Inc. | Technavio

Retrieved on: 
Tuesday, December 10, 2019
Health, General Health, Health, Medicine, Clinical medicine, Throat lozenge, Throat lozenges, Pastille, Vocalzone Throat Pastilles, Cough, Drop

The market is driven by the advantages of throat pastilles and cough drops over other dosage forms.

Key Points: 
  • The market is driven by the advantages of throat pastilles and cough drops over other dosage forms.
  • Also, the emergence of innovative products is anticipated to further boost the growth of the throat pastilles and cough drops market.
  • Thus, the advantages of throat pastilles and cough drops over other dosage forms is expected to drive market growth during the forecast period.
  • Kestrel Medical Ltd. is headquartered in the UK and offers Vocalzone as its vital offering for the throat pastilles and cough drops market.